Literature DB >> 12133929

The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.

J F Nygård1, G B Skare, S Ø Thoresen.   

Abstract

OBJECTIVES: Changes in the incidence of cervical cancer were studied to assess the impact of the Norwegian coordinated cervical cancer screening programme introduced in 1995. Attention was given as to whether recommendation letters sent to women without a screen in the previous 3 years could be an alternative to a conventional screening programme that invites women irrespectively of their spontaneous screening.
SETTING: A population based, nationwide, screening programme in which women of 25 to 69 are recommended to have a conventional Pap smear every 3 years.
METHODS: The impact of the screening programme was assessed indirectly by comparing trends in invasive cervical cancer, changes in coverage, and changes in interval between Pap smears in the 3 year period (1992-4) before screening with the two first screening rounds (1995-7 and 1998-2000). All Pap smears taken from women of all ages were included, a total of 4 744 967 Pap smears from more than 1.4 million women. Further, the impact was assessed directly by logistic regression by comparing the screening results of women recruited for the programme with women who had regularly had Pap smears.
RESULTS: In the last 2 years studied, the incidence of invasive cancer was 22% lower than in the period before the programme. The proportion of women who had a Pap smear was higher after the implementation of the coordinated screening programme. The number of smears taken was less as the interval after a normal smear was greater. The newly recruited women had a threefold risk of having a high grade precursor and a 20-fold higher risk of cancer than the women who had had regular smears.
CONCLUSIONS: The coordinated screening programme provides a low cost way of increasing the coverage of the female population, and consequently has reduced the rate of invasive cervical cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12133929     DOI: 10.1136/jms.9.2.86

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  34 in total

1.  High-grade cervical lesions among women attending a reference clinic in Brazil: associated factors and comparison among screening methods.

Authors:  Neide T Boldrini; Luciana B Freitas; Amanda R Coutinho; Flavia Z Loureiro; Liliana C Spano; Angélica E Miranda
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

2.  How does information on the harms and benefits of cervical cancer screening alter the intention to be screened?: a randomized survey of Norwegian women.

Authors:  Anita L Iyer; M Kate Bundorf; Dorte Gyrd-Hansen; Jeremy D Goldhaber-Fiebert; Pascale-Renée Cyr; Ivar Sønbø Kristiansen
Journal:  Eur J Cancer Prev       Date:  2019-03       Impact factor: 2.497

3.  Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS).

Authors:  Wendy Nelson; Richard P Moser; Allison Gaffey; William Waldron
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

4.  Postpartum HPV Vaccination Rate and Differences in Background Characteristics Between HPV Vaccinated and Unvaccinated Postpartum Women: Strict Monitoring and Follow-Up of Postpartum HPV Vaccination Program.

Authors:  Chung-Yuan Lee; Chih-Jen Tseng; Chi-Chang Chang; Meng-Chih Lee; Shun-Fa Yang
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

5.  Effect of a community-based intervention to increase participation in cervical cancer screening among Pakistani and Somali women in Norway.

Authors:  Samera Azeem Qureshi; Jannicke Igland; Kathy Møen; Abdi Gele; Bernadette Kumar; Esperanza Diaz
Journal:  BMC Public Health       Date:  2021-06-30       Impact factor: 3.295

6.  Evidence for cervical cancer mortality with screening program in Taiwan, 1981-2010: age-period-cohort model.

Authors:  Shih-Yung Su; Jing-Yang Huang; Chien-Chang Ho; Yung-Po Liaw
Journal:  BMC Public Health       Date:  2013-01-08       Impact factor: 3.295

7.  HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy.

Authors:  Sveinung Wergeland Sørbye; Marc Arbyn; Silje Fismen; Tore Jarl Gutteberg; Elin Synnøve Mortensen
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

8.  Risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) among women with HPV-test in 1990-1992, a 30-year follow-up study.

Authors:  Marit Østlyngen Riibe; Sveinung Wergeland Sørbye; Gunnar Skov Simonsen; Arnfinn Sundsfjord; Josef Ekgren; Jan Martin Maltau
Journal:  Infect Agent Cancer       Date:  2021-06-22       Impact factor: 2.965

Review 9.  A systematic review of interventions to enhance access to best practice primary health care for chronic disease management, prevention and episodic care.

Authors:  Elizabeth Jean Comino; Gawaine Powell Davies; Yordanka Krastev; Marion Haas; Bettina Christl; John Furler; Anthony Raymont; Mark F Harris
Journal:  BMC Health Serv Res       Date:  2012-11-21       Impact factor: 2.655

Review 10.  A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence.

Authors:  Helen I Anyasi; Anna M Foss
Journal:  Int Health       Date:  2021-07-03       Impact factor: 2.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.